Lord's Mark Industries Releases H1 Investor Presentation Outlining Growth Strategy and Targets
Lords Mark Industries Ltd · Investor Presentation · 18 Nov 2026, 1:08 am
Lord's Mark Industries Releases H1 Investor Presentation Outlining Growth Strategy and Targets Lord's Mark Industries outlined its strategic roadmap and financial projections across MedTech, diagnostics, and renewable energy. The company forecasts revenue to expand 3.6x from ₹710 Cr in FY25 to ₹2,586 Cr by FY29, driven by high-margin IVD, MedTech, and dialysis segments. Over the same timeframe, EBITDA is expected to grow 8.7x to ₹650.36 Cr (margin reaching 25.1%), with adjusted PAT climbing to ₹422 Cr. The company holds a secured order book of ~₹2,000 Cr in renewable energy and plans a ₹500 Cr FPO or preferential allotment in FY27.
Original exchange filing (PDF)
More announcements from Lords Mark Industries Ltd
- Investor Meet on 19th Nov 2026 · 16 Nov 2026
- Revised Outcome of BM held on 14 Nov 2026 · 15 Nov 2026
- Revised financials for September 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14.11.2026 · 14 Nov 2026
- September 2026 results · 14 Nov 2026
- Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Board Meeting intimation .... · 14 Nov 2026
- Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years . · 03 Nov 2026
- Regulation 30 intimation · 30 Oct 2026
